This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: Tetsuo Hirooka: Innovator in Pharmacological Compounds
Introduction
Tetsuo Hirooka is a notable inventor based in Settsu, Japan. He has made significant contributions to the field of pharmacology through his innovative research and development of new compounds. His work has implications for various therapeutic applications, showcasing the potential of his inventions in medical science.
Latest Patents
Hirooka holds a patent for "3-Substituted-1,2-benzisoxazoles and pharmaceutically acceptable acid." This patent includes a derivative formula where R₁ can be hydrogen, hydroxy, nitro, alkyl, alkoxy, halogen, or amino. R₂ can take on various forms, including hydroxyamino, amino, and several others, which may combine with an imino group to form heterocyclic rings. The compounds he developed exhibit valuable pharmacological properties, such as anti-reserpine activity, central nervous depressing activity, anti-hypertensive activity, and l-dopa potentiating activity. Hirooka has 1 patent to his name.
Career Highlights
Hirooka is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new medications that address critical health issues. His innovative approach and dedication to research have made him a respected figure in the pharmaceutical industry.
Collaborations
Hirooka has collaborated with notable colleagues, including Masanao Shimizu and Hitoshi Uno. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in pharmacology.
Conclusion
Tetsuo Hirooka's contributions to the field of pharmacology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic compounds that can improve health outcomes.